{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:25:24Z","timestamp":1792110324198,"version":"4.4.0"},"reference-count":172,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["onlinejcf.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.cardfail.2023.01.009","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T08:56:36Z","timestamp":1677056196000},"page":"479-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support"],"prefix":"10.1016","volume":"29","author":[{"given":"Barry","family":"Trachtenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JENNIFER","family":"COWGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DOUGLAS L.","family":"JENNINGS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GILLIAN","family":"GRAFTON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RENZO","family":"LOYAGA-RENDON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"REBECCA","family":"COGSWELL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIVIU","family":"KLEIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PALAK","family":"SHAH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHAEL","family":"KIERNAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ESTHER","family":"VOROVICH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2023.01.009_bib0001","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.2022.16197","volume":"328","author":"Mehra","year":"2022","journal-title":". JAMA"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0002","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.healun.2021.02.010","article-title":"Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices - The CLEAR-LVAD study","volume":"40","author":"Pagani","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0003","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.athoracsur.2021.05.017","article-title":"Concordance of treatment effect: an analysis of the Society of Thoracic Surgeons INTERMACS database","volume":"113","author":"Pagani","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0004","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.athoracsur.2021.12.011","article-title":"Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: readmissions after left ventricular assist device","volume":"113","author":"Shah","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0005","first-page":"772","volume":"77","author":"Writing","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0006","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1016\/j.cardfail.2022.02.010","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"28","author":"Heidenreich","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0007","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.healun.2019.11.016","article-title":"Outcomes based on blood pressure in patients on continuous flow left ventricular assist device support: an Interagency Registry for Mechanically Assisted Circulatory Support analysis","volume":"39","author":"Cowger","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0008","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jchf.2018.05.012","article-title":"HVAD: the ENDURANCE Supplemental Trial","volume":"6","author":"Milano","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0009","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jchf.2015.05.011","article-title":"The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies","volume":"3","author":"Teuteberg","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0011","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MAT.0000000000000812","article-title":"Impact of 30 day readmission after left ventricular assist device implantation","volume":"65","author":"Gupta","year":"2019","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0012","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.athoracsur.2020.12.038","article-title":"The Society of Thoracic Surgeons INTERMACS 2020 annual report","volume":"111","author":"Molina","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0013","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jchf.2015.10.001","article-title":"Hemodynamic ramp tests in patients with left ventricular assist devices","volume":"4","author":"Uriel","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0014","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MAT.0000000000000617","article-title":"Unrecognized left heart failure in LVAD recipients: the role of routine invasive hemodynamic testing","volume":"64","author":"Shah","year":"2018","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007991","article-title":"Framework to classify reverse cardiac remodeling with mechanical circulatory support: the Utah-Inova stages","volume":"14","author":"Shah","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0016","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jchf.2016.09.014","article-title":"Significance of residual mitral regurgitation after continuous flow left ventricular assist device implantation","volume":"5","author":"Kassis","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0017","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.healun.2015.06.015","article-title":"Right ventricular failure after left ventricular assist devices","volume":"34","author":"Lampert","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0018","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jtcvs.2019.06.134","article-title":"Avoiding the \"set it and forget it mentality\": a need to regularly reassess left ventricular assist device patients for optimal support","volume":"159","author":"Cowger","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0019","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamacardio.2019.4965","article-title":"Neurohormonal blockade and clinical outcomes in patients with heart failure supported by left ventricular assist devices","volume":"5","author":"McCullough","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0020","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.120.046415","article-title":"Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): medium-term and primary end point results","volume":"142","author":"Birks","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0021","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.echo.2015.05.008","article-title":"Echocardiography in the management of patients with left ventricular assist devices: recommendations from the American Society of Echocardiography","volume":"28","author":"Stainback","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0022","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ccl.2018.06.001","article-title":"Continuous-flow device engineering and pump technology","volume":"36","author":"Tang","year":"2018","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0023","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MAT.0000000000001497","article-title":"Variability in blood pressure assessment in patients supported with the HeartMate 3TM","volume":"68","author":"Cowger","year":"2022","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0024","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/CIRCHEARTFAILURE.114.002000","article-title":"Blood pressure and adverse events during continuous flow left ventricular assist device support","volume":"8","author":"Saeed","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.healun.2014.09.042","article-title":"Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke","volume":"34","author":"Nassif","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0026","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCULATIONAHA.118.037231","article-title":"comprehensive analysis of stroke in the long-term cohort of the MOMENTUM 3 Study","volume":"139","author":"Colombo","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0027","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.healun.2019.11.016","article-title":"Outcomes based on blood pressure in patients on continuous flow left ventricular assist device support: an Interagency Registry for Mechanically Assisted Circulatory Support analysis","volume":"39","author":"Cowger","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0028","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MAT.0000000000001716","article-title":"Special considerations for durable left ventricular assist device use in small patients","volume":"68","author":"Bourque","year":"2022","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0029","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.cardfail.2021.06.007","article-title":"Safety of contemporary heart failure therapy in patients with continuous-flow left ventricular assist devices","volume":"27","author":"Schnettler","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0030","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1097\/MAT.0000000000001435","article-title":"Angiotensin receptor-neprilysin inhibition improves blood pressure and heart failure control in left ventricular assist device patients","volume":"67","author":"Goldberg","year":"2021","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0031","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/0391398821989066","article-title":"Angiotensin receptor neprilysin inhibitor use in patients with left ventricular assist devices: a single-center experience","volume":"45","author":"Alishetti","year":"2022","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0032","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0033","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jamacardio.2021.4567","article-title":"Effect of treatment with sacubitril\/valsartan in patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial","volume":"7","author":"Mann","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0034","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.healun.2022.05.015","article-title":"Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support","volume":"41","author":"Kanwar","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.athoracsur.2018.11.011","article-title":"The Society of Thoracic Surgeons INTERMACS database annual report: evolving indications, outcomes, and scientific partnerships","volume":"107","author":"Kormos","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0036","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003863","article-title":"Early right ventricular assist device use in patients undergoing continuous-flow left ventricular assist device implantation: incidence and risk factors from the interagency registry for mechanically assisted circulatory support","volume":"10","author":"Kiernan","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0037","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.healun.2016.08.010","article-title":"The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device","volume":"36","author":"Rich","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0038","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MAT.0000000000001169","article-title":"High right ventricular afterload is associated with impaired exercise tolerance in patients with left ventricular assist devices","volume":"67","author":"Ton","year":"2021","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0039","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.jacc.2021.09.1362","article-title":"Evolution of late right heart failure with left ventricular assist devices and association with outcomes","volume":"78","author":"Rame","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.healun.2021.07.011","article-title":"Long-term survival on LVAD support: device complications and end-organ dysfunction limit long-term success","volume":"41","author":"Hariri","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0041","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.healun.2020.03.010","article-title":"Updated definitions of adverse events for trials and registries of mechanical circulatory support: a consensus statement of the mechanical circulatory support academic research consortium","volume":"39","author":"Kormos","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0043","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1513\/AnnalsATS.201312-446FR","article-title":"Management of acute right ventricular failure in the intensive care unit","volume":"11","author":"Ventetuolo","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0044","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1016\/j.jtcvs.2014.05.044","article-title":"Right ventricular architecture responsible for mechanical performance: unifying role of ventricular septum","volume":"148","author":"Buckberg","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0045","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jtcvs.2014.04.002","article-title":"Effect of right ventricular free wall ventriculotomy on right ventricular function: is that the correct question?","volume":"148","author":"Buckberg","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0046","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jcmg.2016.12.019","article-title":"3D morphological changes in LV and RV during LVAD ramp studies","volume":"11","author":"Addetia","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0047","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004255","article-title":"Intersection of pulmonary hypertension and right ventricular dysfunction in patients on left ventricular assist device support: is there a role for pulmonary vasodilators?","volume":"11","author":"Sparrow","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0048","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jacc.2020.06.069","article-title":"Pulmonary hypertension in HFpEF and HFrEF: JACC review topic of the week","volume":"76","author":"Guazzi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0049","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/MAT.0000000000001088","article-title":"Right ventricular failure post-implantation of left ventricular assist device: prevalence, pathophysiology, and predictors","volume":"66","author":"Ali","year":"2020","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0050","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.cardfail.2021.01.004","article-title":"Understanding longitudinal changes in pulmonary vascular resistance after left ventricular assist device implantation","volume":"27","author":"Gulati","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0051","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cardfail.2020.12.018","article-title":"Phosphodiesterase-5 inhibitors and outcomes during left ventricular assist device support: a systematic review and meta-analysis","volume":"27","author":"Kittipibul","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0052","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008613","article-title":"Outcomes with phosphodiesterase-5 inhibitor use after left ventricular assist device: an STS-INTERMACS analysis","volume":"15","author":"Grandin","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0053","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MAT.0000000000001159","article-title":"Correction of high afterload improves low cardiac output in patients supported on left ventricular assist device therapy","volume":"67","author":"Rosenbaum","year":"2021","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0054","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12871-018-0645-y","article-title":"Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors","volume":"18","author":"de Waal","year":"2018","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0055","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.healun.2019.05.007","article-title":"Prognostic value of vasoactive-inotropic score following continuous flow left ventricular assist device implantation","volume":"38","author":"Han","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0056","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008377","article-title":"Determinants and outcomes of vasoplegia following left ventricular assist device implantation","volume":"7","author":"Tecson","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0057","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MAT.0000000000001419","article-title":"Defining vasoplegia following durable, continuous flow left ventricular assist device implantation","volume":"68","author":"Swan","year":"2022","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0058","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options","volume":"24","author":"Busse","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0059","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13019-019-0895-x","article-title":"Right ventricular failure following left ventricular assist device implantation is associated with a preoperative pro-inflammatory response","volume":"14","author":"Tang","year":"2019","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.amjms.2020.01.012","article-title":"Reinterpreting renal hemodynamics: the importance of venous congestion and effective organ perfusion in acute kidney injury","volume":"359","author":"Kopitko","year":"2020","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0061","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4103\/0970-9185.74599","article-title":"Methylene blue: revisited","volume":"26","author":"Ginimuge","year":"2010","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0062","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jtcvs.2003.09.046","article-title":"Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass","volume":"127","author":"Evora","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0063","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1067\/mtc.2001.115153","article-title":"Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation","volume":"122","author":"Kofidis","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0064","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0022-5223(02)73284-4","article-title":"Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?","volume":"125","author":"Leyh","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0065","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.athoracsur.2020.05.172","article-title":"Methylene blue does not improve vasoplegia after left ventricular assist device implantation","volume":"111","author":"Saha","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0066","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.930890","article-title":"Use of intravenous hydroxocobalamin without methylene blue for refractory vasoplegic syndrome after cardiopulmonary bypass","volume":"22","author":"Peyko","year":"2021","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0067","doi-asserted-by":"crossref","first-page":"e0408","DOI":"10.1097\/CCE.0000000000000408","article-title":"Hydroxocobalamin in refractory septic shock: a retrospective case series","volume":"3","author":"Sacco","year":"2021","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0068","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/ccr3.2967","article-title":"The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients","volume":"8","author":"Ayers","year":"2020","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0069","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.jvca.2019.08.034","article-title":"A pilot, double-blind, randomized, controlled trial of high-dose intravenous vitamin C for vasoplegia after cardiac surgery","volume":"34","author":"Yanase","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0070","article-title":"Management of stroke in patients with left ventricular assist devices","volume":"29","author":"Giede-Jeppe A, Roeder SS, Macha K","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0071","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0895-7061(04)00863-5","article-title":"Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects","volume":"17","author":"Angeli","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0072","unstructured":"HeartMate II left ventricular assist device instructions for use. Chicago: Abbott; 2023"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0073","series-title":"HeartMate 3 instructions for use","year":"2023"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0074","unstructured":"HVAD System Instructions for Use. HeartWare, Inc., Framingham, MA, USA. 01\/17."},{"key":"10.1016\/j.cardfail.2023.01.009_bib0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MAT.0000000000000714","article-title":"Left lateral thoracotomy for centrifugal continuous-flow left ventricular assist device placement: an analysis from the Mechanical Circulatory Support Research Network","volume":"64","author":"Maltais","year":"2018","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0076","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MAT.0000000000000317","article-title":"Comparison of anticoagulation strategies after left ventricular assist device implantation","volume":"62","author":"Kantorovich","year":"2016","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0077","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/aor.12168","article-title":"Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices","volume":"38","author":"Pieri","year":"2014","journal-title":"Artif Organs"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0078","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.healun.2014.08.022","article-title":"Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients","volume":"33","author":"McIlvennan","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0079","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jchf.2014.11.009","article-title":"Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support","volume":"3","author":"Adatya","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0080","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002680","article-title":"Relationship between anticoagulation intensity and thrombotic or bleeding outcomes among outpatients with continuous-flow left ventricular assist devices","volume":"9","author":"Nassif","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0081","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/MAT.0000000000000592","article-title":"Anticoagulation control in patients with ventricular assist devices","volume":"63","author":"Boehme","year":"2017","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0082","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11239-018-01800-x","article-title":"Impact of time in therapeutic range after left ventricular assist device placement: a comparison between thrombus and thrombus-free periods","volume":"47","author":"Lea","year":"2019","journal-title":"J Thrombos Thrombolys"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0083","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/phar.2324","article-title":"Predictors of warfarin time in therapeutic range after continuous-flow left ventricular assist device","volume":"39","author":"Henderson","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0084","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/aor.13116","article-title":"Meta-analysis of time in therapeutic range in continuous-flow left ventricular assist device patients receiving warfarin","volume":"42","author":"Martinez","year":"2018","journal-title":"Artif Organs"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0085","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1111\/aor.13848","article-title":"The use of direct oral anticoagulants in patients with ventricular assist devices: is there hope for Factor Xa inhibition?","volume":"45","author":"Meredith","year":"2021","journal-title":"Artif Organs"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0086","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s11748-020-01371-w","article-title":"Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices","volume":"68","author":"Parikh","year":"2020","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0087","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.jtcvs.2015.10.059","article-title":"Anticoagulation with apixaban in a patient with a left ventricular assist device and gastrointestinal bleeding: a viable alternative to warfarin?","volume":"151","author":"Pollari","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0088","article-title":"Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial","volume":"10","author":"Andreas","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0089","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MAT.0000000000000612","article-title":"Increased risk of bleeding in left ventricular assist device patients treated with enoxaparin as bridge to therapeutic international normalized ratio","volume":"64","author":"Bhatia","year":"2018","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13019-020-01373-y","article-title":"The use of enoxaparin as bridge to therapeutic INR after LVAD implantation","volume":"15","author":"Shah","year":"2020","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0091","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.healun.2018.03.002","article-title":"Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study","volume":"37","author":"Netuka","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0092","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MAT.0000000000000047","article-title":"Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center","volume":"60","author":"Bishop","year":"2014","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0093","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2016.05.030","article-title":"A multidisciplinary team-based process improves outpatient anticoagulation quality with continuous-flow left-ventricular assist devices","volume":"218","author":"Kuyumjian","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0094","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.healun.2020.01.1329","article-title":"American Association for Thoracic Surgery\/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support","volume":"39","author":"Editors","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0095","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1161\/CIRCULATIONAHA.113.007911","article-title":"Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures","volume":"130","author":"Milano","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0096","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.healun.2013.12.001","article-title":"An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial","volume":"33","author":"Najjar","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0097","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.healun.2020.03.001","article-title":"Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: an analysis from the MOMENTUM 3 study","volume":"39","author":"Saeed","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0098","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/ejhf.2275","article-title":"Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial","volume":"23","author":"Mehra","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0099","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/STROKEAHA.118.022967","article-title":"Stroke incidence and impact of continuous-flow left ventricular assist devices on cerebrovascular physiology","volume":"50","author":"Cornwell","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0100","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1161\/STROKEAHA.111.000396","article-title":"Education strategies for stroke prevention","volume":"44","author":"Boden-Albala","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0101","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ejcts\/ezz098","article-title":"2019 EACTS Expert Consensus on long-term mechanical circulatory support","volume":"56","author":"Potapov","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0102","doi-asserted-by":"crossref","first-page":"521","DOI":"10.21037\/atm-20-4849","article-title":"Antiplatelet and anticoagulation strategies for left ventricular assist devices","volume":"9","author":"Loyaga-Rendon","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0103","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.athoracsur.2019.01.016","article-title":"Reversal and resumption of antithrombotic therapy in LVAD-associated intracranial hemorrhage","volume":"108","author":"Cho","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0104","doi-asserted-by":"crossref","first-page":"e967","DOI":"10.1161\/CIR.0000000000000673","article-title":"Device therapy and arrhythmia management in left ventricular assist device recipients: a scientific statement from the American Heart Association","volume":"139","author":"Gopinathannair","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0106","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0107","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/HCO.0000000000000729","article-title":"Atrial arrhythmias in patients with left ventricular assist devices","volume":"35","author":"Ozcan","year":"2020","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0108","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005340","article-title":"Atrial arrhythmias and electroanatomical remodeling in patients with left ventricular assist devices","volume":"6","author":"Deshmukh","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0109","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jacep.2018.11.016","article-title":"Atrial tachyarrhythmias among patients with left ventricular assist devices: prevalence, clinical outcomes, and impact of rhythm control strategies","volume":"5","author":"Noll","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jacep.2019.02.007","article-title":"Atrial arrhythmias in patients with left ventricular assist devices: to treat or not to treat?","volume":"5","author":"Tung","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0111","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/chf.12034","article-title":"Catheter ablation of atrial flutter in patients with left ventricular assist device improves symptoms of right heart failure","volume":"19","author":"Hottigoudar","year":"2013","journal-title":"Congest Heart Failure"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0112","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.hrthm.2021.03.047","article-title":"Electrical storm in patients with left ventricular assist devices: risk factors, incidence, and impact on survival","volume":"18","author":"Rehorn","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0113","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/HCO.0000000000000730","article-title":"Management of ventricular arrhythmias in patients with LVAD","volume":"35","author":"Maradey","year":"2020","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0114","doi-asserted-by":"crossref","first-page":"e1115","DOI":"10.1161\/CIR.0000000000000504","article-title":"Cardiopulmonary resuscitation in adults and children with mechanical circulatory support: a scientific statement from the American Heart Association","volume":"135","author":"Peberdy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0115","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011813","article-title":"Implantable cardioverter defibrillators in patients with continuous flow left ventricular assist devices: utilization patterns, related procedures, and complications","volume":"8","author":"Alvarez","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0116","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jchf.2017.08.014","article-title":"Implantable cardioverter-defibrillators in patients with a continuous-flow left ventricular assist device: an analysis of the INTERMACS registry","volume":"5","author":"Clerkin","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0117","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.gie.2014.03.040","article-title":"GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis","volume":"80","author":"Draper","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0118","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.healun.2021.01.012","article-title":"Safety of reduced anti-thrombotic strategy in patients with HeartMate 3 left ventricular assist device","volume":"40","author":"Marshall","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0119","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MAT.0000000000000758","article-title":"Gastrointestinal bleeding in left ventricular assist device: octreotide and other treatment modalities","volume":"64","author":"Molina","year":"2018","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0120","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.healun.2017.12.017","article-title":"Limited usefulness of endoscopic evaluation in patients with continuous-flow left ventricular assist devices and gastrointestinal bleeding","volume":"37","author":"Axelrad","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0121","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jchf.2014.11.008","article-title":"Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System","volume":"3","author":"Goldstein","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0122","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/CRD.0000000000000212","article-title":"Gastrointestinal bleeding during continuous-flow left ventricular assist device support: state of the field","volume":"27","author":"Kataria","year":"2019","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0123","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/0391398820951811","article-title":"Angiotensin II antagonists and gastrointestinal bleeding in left ventricular assist devices: A systematic review and meta-analysis","volume":"44","author":"Kittipibul","year":"2021","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0124","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10620-016-4379-8","article-title":"Left ventricular assist devices impact hospital resource utilization without affecting patient mortality in gastrointestinal bleeding","volume":"62","author":"Li","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0125","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/03913988211013366","article-title":"Impact of heart failure drug therapy on rates of gastrointestinal bleeding in LVAD recipients: an INTERMACS analysis","volume":"441","author":"Jennings","year":"2021","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0126","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1073\/pnas.122109599","article-title":"Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF)","volume":"99","author":"Visconti","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0127","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10741-020-10019-z","article-title":"A reappraisal of the pharmacologic management of gastrointestinal bleeding in patients with continuous flow left ventricular assist devices","volume":"26","author":"Littlefield","year":"2021","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","article-title":"Iron deficiency in heart failure: an overview","volume":"7","author":"von Haehling","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0129","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.healun.2015.06.018","article-title":"Safety of reduced anti-thrombotic strategies in HeartMate II patients: a one-year analysis of the US-TRACE Study","volume":"34","author":"Katz","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0130","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.athoracsur.2016.07.072","article-title":"Outcomes in HeartMate II patients with no antiplatelet therapy: 2-year results from the European TRACE Study","volume":"103","author":"Netuka","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0131","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s10620-010-1193-6","article-title":"Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies","volume":"55","author":"Brown","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0132","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cardfail.2018.01.011","article-title":"Long-acting octreotide reduces the recurrence of gastrointestinal bleeding in patients with a continuous-flow left ventricular assist device","volume":"24","author":"Juricek","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0133","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.athoracsur.2012.02.035","article-title":"Incidence and management of gastrointestinal bleeding with continuous flow assist devices","volume":"93","author":"Aggarwal","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0134","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MAT.0000000000000491","article-title":"Tolerability and biological effects of long-acting octreotide in patients with continuous flow left ventricular assist devices","volume":"63","author":"Malhotra","year":"2017","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0135","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/phar.2016","article-title":"Pharmacotherapeutic management of gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices","volume":"37","author":"Sieg","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0136","doi-asserted-by":"crossref","first-page":"19579","DOI":"10.1073\/pnas.0809763105","article-title":"Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0137","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.healun.2021.03.005","article-title":"Association between digoxin use and gastrointestinal bleeding in contemporary continuous flow left ventricular assist device support","volume":"40","author":"El Rafei","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0138","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2011.07.018","article-title":"Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation","volume":"141","author":"Ge","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0139","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MAT.0000000000001054","article-title":"Thalidomide use reduces risk of refractory gastrointestinal bleeding in patients with continuous flow left ventricular assist devices","volume":"66","author":"Namdaran","year":"2020","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0140","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005082","article-title":"Omega-3 therapy is associated with reduced gastrointestinal bleeding in patients with continuous-flow left ventricular assist device","volume":"11","author":"Imamura","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0141","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jchf.2015.06.016","article-title":"Inhibition of ADAMTS-13 by doxycycline reduces von Willebrand factor degradation during supraphysiological shear stress: therapeutic implications for left ventricular assist device-associated bleeding","volume":"3","author":"Bartoli","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0142","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.healun.2020.02.012","article-title":"Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding","volume":"39","author":"Asleh","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0143","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cgh.2014.06.021","article-title":"Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis","volume":"13","author":"Jiang","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0144","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.healun.2015.12.025","article-title":"Serotonergic agents increase the incidence of gastrointestinal bleeds in patients with continuous-flow left ventricular assist devices","volume":"35","author":"Schultz","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0145","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.healun.2019.02.006","article-title":"Stroke and death risk in ventricular assist device patients varies by ISHLT infection category: An INTERMACS analysis","volume":"38","author":"Shah","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0146","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cardfail.2014.10.019","article-title":"Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents","volume":"21","author":"Trachtenberg","year":"2015","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0147","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ahj.2019.04.021","article-title":"Risk factors and prognostic impact of left ventricular assist device-associated infections","volume":"214","author":"Tattevin","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0148","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.healun.2019.01.007","article-title":"Epidemiology of infection in mechanical circulatory support: a global analysis from the ISHLT Mechanically Assisted Circulatory Support Registry","volume":"38","author":"Hannan","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0149","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.healun.2017.06.007","article-title":"An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection","volume":"36","author":"Kusne","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0150","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/aor.12254","article-title":"Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices","volume":"38","author":"Jennings","year":"2014","journal-title":"Artif Organs"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0151","doi-asserted-by":"crossref","first-page":"233","DOI":"10.21037\/acs-2020-cfmcs-26","article-title":"Continuous-flow left ventricular assist device systems infections: current outcomes and management strategies","volume":"10","author":"Aburjania","year":"2021","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0152","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006058","article-title":"Psychosocial evaluation of candidates for heart transplant and ventricular assist devices: beyond the current consensus","volume":"12","author":"Bui","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0153","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.006910","article-title":"Psychosocial risk and its association with outcomes in continuous-flow left ventricular assist device patients","volume":"13","author":"DeFilippis","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0154","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ahj.2015.08.012","article-title":"Psychosocial characteristics and outcomes in patients with left ventricular assist device implanted as destination therapy","volume":"170","author":"Snipelisky","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0155","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.119.041910","article-title":"Suicide attempts among LVAD recipients: real-life data from the ASSIST-ICD study","volume":"141","author":"Charton","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0156","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MAT.0000000000000681","article-title":"The relationship of anxiety, depression, and quality of life in adults with left ventricular assist devices","volume":"64","author":"Casida","year":"2018","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0157","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1097\/MAT.0000000000000736","article-title":"Do psychosocial factors have any impact on outcomes after left ventricular assist device implantation?","volume":"64","author":"Lundgren","year":"2018","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0158","first-page":"0","article-title":"Depression and anxiety in patients undergoing left ventricular assist device implantation","author":"Lundgren","year":"2017","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0159","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jchf.2020.03.011","article-title":"Psychiatric comorbidity and outcomes after left ventricular assist device implantation for end-stage heart failure","volume":"8","author":"Mullan","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0160","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/JCN.0000000000000378","article-title":"Quality of life, depression, and anxiety in ventricular assist device therapy: longitudinal outcomes for patients and family caregivers","volume":"32","author":"Bidwell","year":"2017","journal-title":"J Cardiovasc Nurs"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0161","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/JCN.0000000000000430","article-title":"Implant strategy-specific changes in symptoms in response to left ventricular assist devices","volume":"33","author":"Lee","year":"2018","journal-title":"J Cardiovasc Nurs"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0162","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.psym.2017.02.001","article-title":"Reduced anxiety and depression in patients with advanced heart failure after left ventricular assist device implantation","volume":"58","author":"Yost","year":"2017","journal-title":"Psychosomatics"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0163","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.hrtlng.2014.10.007","article-title":"A comparison of the health status and psychological distress of partners of patients with a left ventricular assist device versus an implantable cardioverter defibrillator: a preliminary study","volume":"44","author":"Brouwers","year":"2015","journal-title":"Heart Lung"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0164","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/JCN.0000000000000774","article-title":"Health-Related Quality of Life in Patients With a Left Ventricular Assist Device (QOLVAD) Questionnaire: initial psychometrics of a new instrument","volume":"36","author":"Sandau","year":"2021","journal-title":"J Cardiovasc Nurs"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0165","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.athoracsur.2020.11.011","article-title":"Patient-reported outcomes measurement information system (PROMIS) in left ventricular assist devices","volume":"113","author":"Ayers","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0166","article-title":"Longitudinal heart failure medication use and adherence following left ventricular assist device implantation in privately insured patients","volume":"6","author":"Tan","year":"2017","journal-title":"J Am Heart Ass"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0167","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.healun.2016.08.023","article-title":"Cognition and adherence are self-management factors predicting the quality of life of adults living with a left ventricular assist device","volume":"36","author":"Casida","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0168","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.healun.2020.04.006","article-title":"Quantifying the impact from stroke during support with continuous flow ventricular assist devices: an STS INTERMACS analysis","volume":"39","author":"Kirklin","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0169","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ncp.10078","article-title":"Effect of vitamin D level on clinical outcomes in patients undergoing left ventricular assist device implantation","volume":"33","author":"Obeid","year":"2018","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0170","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5301\/ijao.5000607","article-title":"Anemia after continuous-flow left ventricular assist device implantation: characteristics and implications","volume":"40","author":"Amione-Guerra","year":"2017","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0171","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2014.04.012","article-title":"Epidemiology and outcomes associated with anemia during long-term support with continuous-flow left ventricular assist devices","volume":"20","author":"Jennings","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0172","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.amjcard.2017.08.004","article-title":"Preoperative prealbumin level as a predictor of outcomes in patients who underwent left ventricular assist device implantation","volume":"120","author":"Critsinelis","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.009_bib0173","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ncp.10238","article-title":"Improved nutrition status in patients with advanced heart failure implanted with a left ventricular assist device","volume":"34","author":"Genev","year":"2019","journal-title":"Nutr Clin Pract"}],"updated-by":[{"DOI":"10.1016\/j.cardfail.2023.06.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000}}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423000398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423000398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T06:46:43Z","timestamp":1715323603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916423000398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":172,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1071916423000398"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.01.009","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}